A high-throughput assessment of drug-induced cardiotoxicity in vitro. The common predictive genomics biomarkers of Rps6kb1 was identified and verified in several drugs. Ingenuity Pathway Analysis (IPA) was applied to combine relevant pathways of RPS6KB1 in human species.